Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 6, 2026 | $0.11 | +450.0% | $1.37B | +10.2% | $0.28 |
| Q1 FY26ended Mar 31, 2026 | May 13, 2026 | $0.11 | −15.4% | $1.37B | +14.9% | $0.35 |
| Q4 FY25ended Dec 31, 2025 | — | −$0.56 | — | $1.14B | +12.2% | — |
| Q3 FY25ended Sep 30, 2025 | — | −$0.07 | −109.6% | $1.14B | +10.4% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.02 | — | $1.24B | +4.8% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.13 | +116.7% | $1.19B | −1.0% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.02 | — | $1.02B | −1.4% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.73 | — | $1.03B | −3.6% | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Elanco Animal Health shares, not any token. As of Aug 6, 2026, from Massive's standardised financials and the earnings calendar.
| Q2 FY24ended Jun 30, 2024 | — | −$0.10 | — | $1.18B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.06 | — | $1.21B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | −$0.29 | — | $1.04B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | −$2.22 | — | $1.07B | — | — |